J&J Innovative Medicine Europe, Middle East & Africa (EMEA)
Developing innovative medicines solutions
- B2B
- B2G
- Has physical offices
- Manufacturing
- Sales-led purchase
About J&J Innovative Medicine Europe, Middle East & Africa (EMEA)
A global pharmaceutical organization dedicated to developing treatments for diseases and collaborating with partners worldwide to improve patient outcomes
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Beerse, Antwerp, Belgium
- Revenue
- $127M – $1BTamtam estimate
- Website
- innovativemedicine.jnj.com
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) in the news
- Focused on developing medicines for some of the world’s most complex and devastating diseases
Janssen Sciences Ireland UC develops innovative medicines for complex diseases, operates major manufacturing sites in Cork, and calls for improved healthcare funding and infrastructure in Ireland to enhance patient access and support value-based care.
- When Europe Treats Healthcare Innovation as a Cost, Patients Pay the Price
Europe's focus on healthcare cost-cutting, driven by budget constraints and aging populations, negatively impacts patients, health systems, and economies by neglecting the long-term value of innovation.
- Harnessing Europe’s Data Potential: How HONEUR Can Help Improve Patient Outcomes
Europe can enhance patient outcomes by better leveraging real-world data through federated networks and policy initiatives to improve healthcare decision-making and access to innovative treatments.
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) at a glance
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) is a B2B/B2G company in the Pharmaceutical Manufacturing industry, headquartered in Beerse, Antwerp, Belgium.
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) has 251–1,000 employees.
J&J Innovative Medicine Europe, Middle East & Africa (EMEA)'s revenue is $127M – $1B (Tamtam estimate).
Frequently asked questions about J&J Innovative Medicine Europe, Middle East & Africa (EMEA)
What is J&J Innovative Medicine Europe, Middle East & Africa (EMEA)'s revenue?
Tamtam estimates J&J Innovative Medicine Europe, Middle East & Africa (EMEA)'s annual revenue at $127M – $1B.
How many employees does J&J Innovative Medicine Europe, Middle East & Africa (EMEA) have?
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) has 251–1,000 employees.
Where is J&J Innovative Medicine Europe, Middle East & Africa (EMEA) headquartered?
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) is headquartered in Beerse, Antwerp, Belgium.
Selling to companies like J&J Innovative Medicine Europe, Middle East & Africa (EMEA)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies